RxDoctor Payments Data

James Alderman

Cardiovascular Disease · Framingham, MANPI 1457342065

Payments from drug & device makers

$2,403in general payments, 2019–2025

Across 111 payments — averaging $21.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$577
  • Amgen$219
  • E.r. Squibb & Sons, L.L.C.$217
  • AstraZeneca$208
  • Novartis$173
  • Esperion Therapeutics, Inc.$125
  • plus $884 from 16 others

What the payments were for

  • Food & beverage$2,36899%
  • Education$351%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,403 in reported general payments places this provider in the 50th percentile of 750 cardiovascular disease providers in Massachusetts.

See all cardiovascular disease providers in Massachusetts

Other cardiovascular disease in Framingham

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →